- Home
- » Tags
- » Ipratropium bromide
Top View
- Newer Therapies in COPD
- Ipratropium Bromide Solution Cobalt Laboratories, Inc.
- Ipratropium Bromide
- CDR Pharmacoeconomic Review Report for Trelegy Ellipta
- 209482Orig1s000
- Stembook 2018.Pdf
- Patient's Instructions for Use Ipratropium Bromide Inhalation
- Use of Inhaled Anticholinergic Agents in Obstructive Airway Disease Ruben D Restrepo MD RRT
- Characterization of Aclidinium Bromide, a Novel Inhaled Muscarinic Antagonist, with Long Duration of Action and a Favorable Pharmacological Profile
- Anticholinergic Syndrome 23 William J
- CDPHP Medicaid Select/HARP Clinical Formulary 2021
- Bretaris Genuair, INN-Aclidinium Bromide
- Inhaled Beta-Agonist Combination Agents
- Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme
- Role of Ipratropium Bromide and Tiotropium in Chronic Obstructive Pulmonary Disease
- Prior Authorization PDL Implementation Schedule
- Intranasal Rhinitis Agents Review 05/07/2008
- Chronic Obstructive Pulmonary Disease (“COPD”) Medication Guide
- Drug Development for Asthma and COPD: a Regulatory Perspective
- Enurev Breezhaler, INN-Glycopyrronium
- 022036Orig1s000
- Medications to Treat Parkinson's Disease
- The Evidence on Tiotropium Bromide in Asthma: from the Rationale to the Bedside Dejan Radovanovic1, Pierachille Santus1, Francesco Blasi2 and Marco Mantero2*
- NIHB Formulary List for FNHA Clients Enrolled in Plan W
- Preferred Drug List (PDL)
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Download Paper
- Hypersalivation Pathway Adults
- Educational Aims • to Discuss Fundamental Questions Relating to the Use of Bronchodilators That Can Lead to an Optimisation of Their Utilisation
- In This Issue
- Insert Ipratropium Bromide 0.02%
- Seasonal Allergic Rhinitis Managing Hay Fever
- Laventair, INN-Umeclidinium Bromide/Vilanterol
- 207923Orig1s000
- Literature Search Strategy for Treatment of Stable
- Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth
- Thoraxjnl-2011-201275.Full.Pdf
- Compatible Stability and Aerosol Characteristics of Atrovent® (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
- 1999 Generic Codes and Names in Numeric Order
- Attachment: Product Information: Tiotropium Bromide
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Appendix A: Prescription Medication Table for COPD1- 4
- Indacaterol Maleate/ Glycopyrronium Bromide
- Clozapine Toolkit
- $9 Generic Medications List
- Xerostomia, Xerogenic Medications and Food Avoidances in Selected Geriatric Groups W
- Oral Inhalers / Nebulizer Solution Quantity Limits List
- The Diagnosis and Management of Rhinitis: an Updated Practice Parameter
- Pathophysiology of Clozapine Induced Sialorrhea and Current
- FNHA Supplementary Formulary Through Pacific Blue Cross
- Comparing the Impact of Atropine Drops and Amitriptyline Tablets In
- Respiratory Beta-Agonist Combination Agents
- Spirivacap.Pdf
- Mhippr Formulary
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- Assessment Report: Anoro. INN: Umeclidinium Bromide/Vilanterol
- International Classification of Procedures in Medicine
- Clinical Review
- Paramedic Medication Manual
- Optimum Value Medication List Generics Are Cheaper Than Brand-Names
- Aclidinium Bromide Improves Symptoms and Sleep Quality in COPD: a Pilot Study
- Application to Add a Long Acting Muscarinic Agent (LAMA) Inhaler to the Essential Medicines List